Study to determine guidelines for pediatric colonoscopy

Table 1 Characteristics of pediatric patients

Total number of patients		n = 110
Age (yr)	0	3
	1–3	14
	4–6	11
	7–9	19
	10–12	32
	13–15	31
Gender	Male	61
	Female	49
Reason for endoscopy	Hematochezia	62
	Abdominal pain	20
	Diarrhea	19
	Anemia	2
	Anal fistula	2
	Genital ulcer	2
	Other	2
Diagnosis	Ulcerative colitis	37
	Crohn’s disease	12
	No specific colitis	13
	Juvenile polyp	7
	Normal	32
	Other	9

Table 2 Bowel cleansing preparation n (%)

Age	n	Magcorol	PEG	GE	Unknown
0	3	2 (66.7)	0 (0.0)	1 (33.3)	0 (0.0)
1-3	14	10 (71.4)	1 (7.1)	1 (7.1)	2 (14.3)
4-6	11	9 (81.8)	0 (0.0)	1 (9.1)	1 (9.1)
7-9	19	15 (78.9)	2 (10.5)	1 (5.3)	1 (5.3)
10-12	32	27 (84.4)	4 (12.5)	1 (3.1)	0 (0.0)
13-15	31	11 (35.5)	20 (64.5)	0 (0.0)	0 (0.0)
Total	110	74 (67.3)	27 (24.5)	5 (4.6)	4 (3.6)

Magcorol: Magnesium citrate; PEG: Polyethylene glycol; GE: Glycerin enema.

Table 3 Sedation n (%)

Age	n	Thiamylal	Thiamylal + Pentazocine	Midazolam	Midazolam + Pentazocine	None	Unknown
0	3	0 (0.0)	1 (33.3)	0 (0.0)	2 (66.7)	0 (0.0)	0 (0.0)
1-3	14	1 (7.1)	7 (50.0)	1 (7.1)	3 (21.4)	0 (0.0)	2 (14.3)
4-6	11	1 (9.1)	5 (45.5)	0 (0.0)	4 (36.4)	0 (0.0)	1 (9.1)
7-9	19	0 (0.0)	2 (10.5)	0 (0.0)	15 (78.9)	0 (0.0)	2 (10.5)
10-12	32	1 (3.1)	4 (12.5)	2 (6.3)	21 (65.6)	4 (12.5)	0 (0.0)
13-15	31	0 (0.0)	1 (3.2)	1 (3.2)	13 (41.9)	16 (38.7)	0 (0.0)
Total	110	3 (2.7)	20 (18.2)	4 (3.6)	58 (52.7)	20 (18.2)	5 (4.5)

Table 4 Length of endoscope n (%)

Age	n	1030 mm	1330 mm
0	3	3 (100.0)	0 (0.0)
1-3	14	11 (78.6)	3 (21.4)
4-6	11	2 (18.2)	9 (81.8)
7-9	19	0 (0.0)	19 (100.0)
10-12	32	0 (0.0)	32 (100.0)
13-15	31	0 (0.0)	31 (100.0)
Total	110	16 (14.5)	94 (85.5)

Table 5 Shaft diameter of endoscope n (%)

Age	n	5.4 mm	9.2 mm	9.8 mm	10.5 mm	11.3 mm	11.7 mm
0	3	3 (100.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
1-3	14	5 (35.7)	4 (28.6)	2 (14.3)	1 (7.1)	1 (7.1)	0 (0.0)
4-6	11	0 (0.0)	3 (27.3)	1 (9.1 )	1 (9.1)	5 (45.5)	1 (9.1)
7-9	19	0 (0.0)	1 (5.3)	0 (0.0)	1 (5.3)	14 (73.7)	3 (15.8)
10-12	32	0 (0.0)	0 (0.0)	0 (0.0)	2 (6.3)	22 (68.8)	9 (28.1)
13-15	31	0 (0.0)	1 (3.2)	0 (0.0)	0 (0.0)	17 (54.8)	13 (41.9)
Total	110	8 (7.3)	9 (8.2)	3 (2.7)	5 (4.5)	59 (53.6)	26 (23.6)

Table 6 Symptoms and final diagnosis n (%)

	n	UC	CD	NSC	JP	Normal	Other
Hematochezia	63	34 (54.0)	1 (1.5)	6 (9.5)	7 (11.1)	9 (14.3)	6 (9.5)
Abdominal pain	20	1 (0.5)	6 (30.0)	2 (10.0)	0 (0.0)	10 (50.0)	1 (0.5)
Diarrhea	19	1 (5.3)	4 (21.1)	3 (15.7)	0 (0.0)	10 (52.6)	1 (5.3)
Anemia	2	1 (50.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (50.0)	0 (0.0)
Anal fistula	2	0 (0.0)	1 (50.0)	1 (50.0)	0 (0.0)	0 (0.0)	0 (0.0)
Genital ulcer	2	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	2 (100.0)
Other	2	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	2 (100.0)	0 (0.0)
Total	110	37 (33.6)	12 (10.9)	12 (10.9)	7 (6.4)	32 (29.1)	10 (9.1)

UC: Ulcerative colitis; CD: Crohn’s disease; NSC: Non-specific colitis; JP: Juvenile polyp.